TPG and Shanghai Fosun Pharmaceutical agree to acquire Chindex for $369 mln

TPG and Shanghai Fosun Pharmaceutical have agreed to acquire Chindex International for approximately $369 million. According to terms of the agreement, the buyers will purchase all outstanding shares of Chindex's common stock for $19.50 per share in cash. The transaction is expected to close in the second half of 2014. Morgan Stanley is serving as financial advisor to Chindex on the transaction while Goldman Sachs is advising TPG. Chindex is a American healthcare company that provides healthcare services in China.

DealsNorth AmericaUSBriefs